The relationship among plasma ghrelin level and H. pylori infection and eradication therapy in patients with chronic kidney disease
Not Applicable
- Conditions
- Hemodialysis patients and non-dialysis patients with chronic kidney disease
- Registration Number
- JPRN-UMIN000023336
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Having a H. pylori eradication history (2)With history of gastrectomy (3)With significant clinical illness (e.g., cancer) (4)Lack of informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association with plasme ghrelin levels and gastric mucosal atrophy in hemodialysis patients
- Secondary Outcome Measures
Name Time Method 1)Association with plasme ghrelin levels and H. pylori infection in hemodialysis patients 2)H. pyloti infection rate in CKD patients 3)Association with plasme ghrelin levels and mutrition markers in CKD patients 4)Prevalence of the upper gastrointestinal disease in CKD patients 5)Eradication rate of H. pylori in CKD patients 6)Change of plasma ghlerin levels after eradicaion therapy 7)Change of nutrition markers after eradicaion therapy